Gökce 2015.

Methods	Case study
Participants	Number of participants screened: no data Number of participants included: no data Number of participants followed up: no data Number of withdrawals: no data Diagnosis of ADHD: combined type ADHD Age: 12 IQ: no data Sex: male Methylphenidate‐naïve: no data Ethnicity: no data Country: no data Comorbidity: no data Comedication: no data Sociodemographics: no data Inclusion criteria: no data Exclusion criteria: no data
Interventions	Methylphenidate type: extended release MPH Methylphenidate dosage: 27 mg from 10 years of age. Suicide attempt: 10 tablets of 36 mg ER‐MPH Administration schedule: not stated Duration of intervention: not stated Treatment compliance: not stated
Outcomes	Non‐serious adverse events: Physical examination: tachycardia and mildly increased blood pressure, respiration and heart rate had been determined Psychiatric examination: his mood was depressed, and tendency to sleep Laboratory tests, blood glucose level, blood urea nitrogen, creatinine, potassium (K), sodium (Na) and chloride (CL) were revealed normal The electrocardiography (ECG) parameters such as QRS duration, QT interval, R wave and PR interval were normal; however, the heart rate was elevated There was no central nervous system finding except irritability and agitation
Notes	No data